Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)

详细信息    查看全文

• 作者：Atul A. Deodhar ; Maxime Dougados ; Dominique L. Baeten ; James Cheng-Chung Wei ; Piet Geusens ; Aimee Readie ; Hanno B. Richards ; Ruvie Martin and Brian Porter
• 刊名：Arthritis & Rheumatism
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：68
• 期：12
• 页码：2901-2910
• 全文大小：264K
• ISSN：1529-0131

文摘

To evaluate the effect of secukinumab (interleukin-17A inhibitor) on patient-reported outcomes in patients with active ankylosing spondylitis (AS).